News AstraZeneca PLC Nasdaq Stockholm

Equities

AZN

GB0009895292

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-12 pm EDT			5-day change	1st Jan Change
1,676 ^SEK	+2.38%		+3.65%	+23.83%

Jul. 12	Instil Bio Shares Surge Following Rental Agreement with AstraZeneca	DJ
Jul. 12	Sector Update: Health Care Stocks Mixed Premarket Friday	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca	Jul. 12	DJ
Sector Update: Health Care Stocks Mixed Premarket Friday	Jul. 12	MT
Instil Bio Signs Lease With AstraZeneca Pharmaceuticals at California Facility; Shares Rise After Hours	Jul. 11	MT
Selkirk Pharma, Inc. - Colleen Dixon Appointed CEO	Jul. 10	AQ
ASTRAZENECA : Deutsche Bank reiterates its Neutral rating	Jul. 10	ZD
Barclays raises Kerry, cuts Hunting, Wood Group	Jul. 10	AN
ASTRAZENECA : JP Morgan reaffirms its Buy rating	Jul. 10	ZD
Non-Hodgkin Lymphoma Pipeline 2024 \| Novartis, AstraZeneca, Genentech, BioInvent, Genmab, SystImmune, Nordic Nanovector, Pacylex Pharmaceuticals, Artiva Biotherapeutics, Inc., Chipscreen Biosciences	Jul. 09	AQ
Metastatic Renal Cell Carcinoma Pipeline 2024 \| AstraZeneca, Genentech, Sumitomo Dainippon Pharma, Allogene Therapeutics, Nektar Therapeutics	Jul. 09	AQ
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series a Cumulative Redeemable Perpetual Preferred Stock	Jul. 08	AQ
Astrazeneca - Tagrisso with the addition of chemotherapy approved in the EU as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer	Jul. 08	AQ
AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer	Jul. 05	MT
AstraZeneca: cancer treatment approved by the EU	Jul. 05	CF
AstraZeneca drug Tagrisso gets EU approval for cancer form	Jul. 05	AN
EU Approves AstraZeneca's Tagrisso Combo as Non-small Cell Lung Cancer Treatment	Jul. 05	MT
BenevolentAI - Leadership team change	Jul. 04	AQ
ASTRAZENECA : Goldman Sachs maintains a Buy rating	Jul. 04	ZD
ASTRAZENECA : Buy rating from Berenberg	Jul. 03	ZD
Aptamer shares jump as inks agreement with AstraZeneca	Jul. 03	AN
Aptamer Group plc Announces New Agreement with AstraZeneca to Evaluate the Optimer Fibrotic Liver Delivery Vehicles for the Targeted Delivery of SiRNA	Jul. 03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT